Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kent A Griffith

Showing results (121-130 of 174) with videos related to

Pageof 18
Sort By:
International Journal of Radiation Oncology, Biology, Physics|May 5, 2009
Gemcitabine-based combination chemotherapy followed by radiation with capecitabine as adjuvant therapy for resected pancreas cancerSameer Desai, Edgar Ben-Josef, Kent A Griffith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2018
Concurrent Veliparib With Chest Wall and Nodal Radiotherapy in Patients With Inflammatory or Locoregionally Recurrent Breast Cancer: The TBCRC 024 Phase I Multicenter StudyReshma Jagsi, Kent A Griffith, Jennifer R Bellon, et al.
JCO Oncology Practice|December 2, 2021
Patient Experiences, Trust, and Preferences for Health Data SharingRochelle D Jones, Chris Krenz, Kent A Griffith, et al.
Annals of Surgical Oncology|December 27, 2005
Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph nodeAeisha K Rivers, Kent A Griffith, Kelly K Hunt, et al.
JCO Oncology Practice|October 23, 2020
Governance of a Learning Health Care System for Oncology: Patient RecommendationsRochelle D Jones, Chris Krenz, Kent A Griffith, et al.
Cancer|November 25, 2003
Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patientsAmy C Degnim, Kent A Griffith, Michael S Sabel, et al.
International Journal of Radiation Oncology, Biology, Physics|August 9, 2014
Quality of life in a prospective, multicenter phase 2 trial of neoadjuvant full-dose gemcitabine, oxaliplatin, and radiation in patients with resectable or borderline resectable pancreatic adenocarcinomaPablo E Serrano, Joseph M Herman, Kent A Griffith, et al.
International Journal of Radiation Oncology, Biology, Physics|September 9, 2019
Phase 2 Trial of Neoadjuvant FOLFIRINOX and Intensity Modulated Radiation Therapy Concurrent With Fixed-Dose Rate-Gemcitabine in Patients With Borderline Resectable Pancreatic CancerNguyen H Tran, Vaibhav Sahai, Kent A Griffith, et al.
American Journal of Clinical Oncology|September 1, 2007
A phase II study of preoperative capecitabine and radiation therapy in patients with rectal cancerSameer P Desai, Basil F El-Rayes, Edgar Ben-Josef, et al.
International Journal of Radiation Oncology, Biology, Physics|May 2, 2006
Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosisFeng-Ming Kong, James A Hayman, Kent A Griffith, et al.
Pageof 18

Showing results (121-130 of 174) with videos related to

Sort By:
Pageof 18
International Journal of Radiation Oncology, Biology, Physics|May 5, 2009
Gemcitabine-based combination chemotherapy followed by radiation with capecitabine as adjuvant therapy for resected pancreas cancerSameer Desai, Edgar Ben-Josef, Kent A Griffith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2018
Concurrent Veliparib With Chest Wall and Nodal Radiotherapy in Patients With Inflammatory or Locoregionally Recurrent Breast Cancer: The TBCRC 024 Phase I Multicenter StudyReshma Jagsi, Kent A Griffith, Jennifer R Bellon, et al.
JCO Oncology Practice|December 2, 2021
Patient Experiences, Trust, and Preferences for Health Data SharingRochelle D Jones, Chris Krenz, Kent A Griffith, et al.
Annals of Surgical Oncology|December 27, 2005
Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph nodeAeisha K Rivers, Kent A Griffith, Kelly K Hunt, et al.
JCO Oncology Practice|October 23, 2020
Governance of a Learning Health Care System for Oncology: Patient RecommendationsRochelle D Jones, Chris Krenz, Kent A Griffith, et al.
Cancer|November 25, 2003
Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patientsAmy C Degnim, Kent A Griffith, Michael S Sabel, et al.
International Journal of Radiation Oncology, Biology, Physics|August 9, 2014
Quality of life in a prospective, multicenter phase 2 trial of neoadjuvant full-dose gemcitabine, oxaliplatin, and radiation in patients with resectable or borderline resectable pancreatic adenocarcinomaPablo E Serrano, Joseph M Herman, Kent A Griffith, et al.
International Journal of Radiation Oncology, Biology, Physics|September 9, 2019
Phase 2 Trial of Neoadjuvant FOLFIRINOX and Intensity Modulated Radiation Therapy Concurrent With Fixed-Dose Rate-Gemcitabine in Patients With Borderline Resectable Pancreatic CancerNguyen H Tran, Vaibhav Sahai, Kent A Griffith, et al.
American Journal of Clinical Oncology|September 1, 2007
A phase II study of preoperative capecitabine and radiation therapy in patients with rectal cancerSameer P Desai, Basil F El-Rayes, Edgar Ben-Josef, et al.
International Journal of Radiation Oncology, Biology, Physics|May 2, 2006
Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosisFeng-Ming Kong, James A Hayman, Kent A Griffith, et al.
Pageof 18